My Member
Message Center
trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
2022 MEDICA Exhibitor’s Recommendation--Hangzhou Medconn Diagnostics Technology Co., Ltd.
2022-11-04
MEDICA is the leading international platform for the medical technology industry. For more than 50 years, it has been a must-attend event in the annual calendar of trade visitors from all areas of the healthcare industry.
Hangzhou Medconn Diagnostics Technology Co., Ltd. will participate in this event at Booth: 17 E46-2 and look forward to meeting you.
Company Profile
Medconn Diagnostics was founded in 1992, focusing on R&D, manufacturing, sales and service of in vitro diagnostic （IVD）products. Medconn Diagnostics is headquartered in Shanghai, China. Its business covers most provinces and regions in China and its products cover HbA1c, Clinical Chemistry, Immunoassay, POCT, etc.
In 2019, we rebuilt the "Medconn Diagnostics" brand, to integrate and improve the product system, and improve the R & D capability and service quality. Medconn Diagnostics includes Shanghai Medconn Diagnostics Technology Co., Ltd., Shanghai Medconn Medical Technology Co., Ltd., Shanghai Medconn Biotechnology Co., Ltd., and Beijing Medconn Medical Devices Co., Ltd. Of the four companies, Shanghai Medconn Diagnostics Technology Co., Ltd. undertakes the functions of marketing center, responsible for unified external sales and service, and the other three companies undertake R & D and production functions.
Medconn Diagnostics Industrial Park is located in Jinshan District, Shanghai. It covers an area of nearly 40,000 square meters and integrates R&D, production, warehousing and logistics functions. As of 2019, the R&D system of Medconn Diagnostics has obtained 9 invention patents, 59 utility model patents, 6 design patents, 7 software Copyrights and 12 Certificates of Transformation of High-tech Achievements; The production facility of Medconn Diagnostics is certified by ISO9001, ISO13485 and GMP, with 10,000-grade purification workshops and 9500 square meters of clean workshops.
In the future, Medconn Diagnostics will continue to adhere to the business philosophy of customer orientation, and continuously improve the product and service quality through technological innovation and service innovation, so as to contribute to the vigorous development of in vitro diagnosis（IVD）industry in China.
Leading Products Display
Hangzhou Medconn Diagnostics Technology Co., Ltd. will participate in this event at Booth: 17 E46-2 and look forward to meeting you.
Company Profile
Medconn Diagnostics was founded in 1992, focusing on R&D, manufacturing, sales and service of in vitro diagnostic （IVD）products. Medconn Diagnostics is headquartered in Shanghai, China. Its business covers most provinces and regions in China and its products cover HbA1c, Clinical Chemistry, Immunoassay, POCT, etc.
In 2019, we rebuilt the "Medconn Diagnostics" brand, to integrate and improve the product system, and improve the R & D capability and service quality. Medconn Diagnostics includes Shanghai Medconn Diagnostics Technology Co., Ltd., Shanghai Medconn Medical Technology Co., Ltd., Shanghai Medconn Biotechnology Co., Ltd., and Beijing Medconn Medical Devices Co., Ltd. Of the four companies, Shanghai Medconn Diagnostics Technology Co., Ltd. undertakes the functions of marketing center, responsible for unified external sales and service, and the other three companies undertake R & D and production functions.
Medconn Diagnostics Industrial Park is located in Jinshan District, Shanghai. It covers an area of nearly 40,000 square meters and integrates R&D, production, warehousing and logistics functions. As of 2019, the R&D system of Medconn Diagnostics has obtained 9 invention patents, 59 utility model patents, 6 design patents, 7 software Copyrights and 12 Certificates of Transformation of High-tech Achievements; The production facility of Medconn Diagnostics is certified by ISO9001, ISO13485 and GMP, with 10,000-grade purification workshops and 9500 square meters of clean workshops.
In the future, Medconn Diagnostics will continue to adhere to the business philosophy of customer orientation, and continuously improve the product and service quality through technological innovation and service innovation, so as to contribute to the vigorous development of in vitro diagnosis（IVD）industry in China.
Leading Products Display
Ranos® Chemiluminescence Immunoassay System
Medconn-Hitachi LABOSPECT 008 AS Biochemical Analyzer System
MQ-6000 HbA1c Analyzer System
MQ-2000PT HbA1c Analyzer System
label :
Medica
